Presentation TCT 2024 TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis Presenter: Mohammad Reza Movahed October 30, 2024
Presentation TCT 2024 TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement Presenter: Constantijn Venema October 30, 2024
Presentation TCT 2024 TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR Presenter: Rishi Sukhija October 30, 2024
Presentation TCT 2024 TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study Presenter: Rupak Banerjee October 30, 2024
Presentation TCT 2024 TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades Presenter: Zaid Abdulelah October 30, 2024
Presentation TCT 2024 TCT 1004: Balloon-Expandable Covered Stent Implantation After Vascular Access Complication in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement Presenter: Hector Alvarez Covarrubias October 30, 2024
Presentation TCT 2024 The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes Presenter: David Wood October 30, 2024
Presentation TCT 2024 Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program! Presenter: Brian Lindman October 30, 2024
Presentation TCT 2024 Can AI-Assisted Earlier AS Diagnosis Level the Disparities Playing Field? Presenter: Pierre Elias October 30, 2024
Presentation TCT 2024 TCT 836: Laser Ablation: A Novel Approach to Mitigate Coronary Obstruction and Maintain Coronary Access in Transcatheter Aortic Valve Replacement Procedures Presenter: Ali Azadani October 30, 2024
Presentation TCT 2024 TCT 834: Percutaneous Coronary Interventions in Patients With Prior Transcatheter Aortic Valve Replacement Presenter: Chloe Kharsa October 30, 2024
Presentation TCT 2024 TCT 833: Fluoroscopic Evaluation of Post Evolut FX Implantation Commissural Alignment With Coronary Artery Ostium Presenter: Yair Feld October 30, 2024
Presentation TCT 2024 TCT 804: Impact of Gender and Race on the Outcomes of Transcatheter Aortic Valve Replacement in Peripheral Arterial Disease Presenter: Junaid Mir October 30, 2024
Presentation TCT 2024 TCT 801: Clinical Impact of Sex Differences and Procedural Setting in Transcatheter Aortic Valve Implantation Presenter: Henrique Ribeiro October 30, 2024
Presentation TCT 2024 TCT 799: Unveiling Demographic Disparities in Aortic Stenosis Mortality: An Analysis of Trends and Data Gaps in the United States Presenter: Mobeen Haider October 30, 2024
Presentation TCT 2024 The Emerging Use of TAVR in Younger Patients: Updates and Evidence Gaps Presenter: Harold Dauerman October 30, 2024
Presentation TCT 2024 Surgical Valve Selection in Younger Patients with AS: Mechanical, Bioprosthetic, or Ross? Presenter: Katherine Harrington October 30, 2024
Presentation TCT 2024 Patient Perspectives and Shared Decision-Making in Younger Patients Requiring AS Therapy Presenter: Megan Coylewright October 30, 2024
Presentation TCT 2024 Lessons From the Moderate AS + HF Trial (TAVR UNLOAD) Presenter: Nicolas Van Mieghem October 30, 2024
Presentation TCT 2024 TCT 961: Immune Thrombocytopenic Purpura Is an Independent Risk Factor for Prosthetic Aortic Valve Degeneration: Analysis of the National Inpatient Sample Database 2019 Presenter: Palak Patel October 30, 2024